| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.513 | 28.135 | 39.826 | 49.130 | 54.471 | 60.407 | 48.486 | 72.894 | 98.170 |
| Total Income - EUR | - | 1.513 | 28.172 | 39.834 | 49.141 | 54.477 | 60.519 | 48.486 | 94.320 | 98.210 |
| Total Expenses - EUR | - | 55 | 15.246 | 26.745 | 35.577 | 33.529 | 59.404 | 43.490 | 74.445 | 83.782 |
| Gross Profit/Loss - EUR | - | 1.458 | 12.927 | 13.089 | 13.564 | 20.949 | 1.115 | 4.996 | 19.875 | 14.428 |
| Net Profit/Loss - EUR | - | 1.413 | 12.082 | 11.894 | 12.090 | 19.789 | 522 | 4.535 | 19.045 | 11.923 |
| Employees | - | 0 | 0 | 1 | 1 | 1 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Pan Reumamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16 | 2.448 | 30.071 | 24.242 | 35.171 | 32.153 | 32.025 | 66.291 | 48.902 |
| Current Assets | - | 1.565 | 11.427 | 13.092 | 23.613 | 26.168 | 6.150 | 15.897 | 26.132 | 40.576 |
| Inventories | - | 0 | 1.963 | 3.753 | 0 | 0 | 0 | 0 | 0 | 1.662 |
| Receivables | - | 1.513 | 2.183 | 3.072 | 2.427 | 1.991 | 2.850 | 2.640 | 5.350 | 874 |
| Cash | - | 52 | 7.281 | 6.266 | 21.186 | 24.177 | 3.301 | 13.257 | 20.782 | 38.040 |
| Shareholders Funds | - | 1.457 | 13.515 | 20.863 | 32.549 | 51.780 | 33.971 | 38.612 | 57.540 | 12.852 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 123 | 360 | 22.299 | 15.305 | 9.559 | 4.332 | 9.310 | 34.931 | 76.626 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pan Reumamed Srl